COMMUNIQUÉS West-GlobeNewswire

-
GW Pharmaceuticals Announces Acceptance of NDA Filing for Epidiolex® (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome
28/12/2017 -
Veritas Pharma Subsidiary Receives Health Canada Dealer Licence
28/12/2017 -
The Financial Calendar of AS Olainfarm for 2018
28/12/2017 -
MDxHealth (R): MDxHealth Announces Lowering of 2017 Guidance
28/12/2017 -
MDxHealth (R) : MDxHealth annonce une baisse des prévisions
28/12/2017 -
The Ensign Group Closes on HUD-Insured Loan Portfolio
27/12/2017 -
Digirad Announces Sale of its MDSS Service Contracts to Philips North America
27/12/2017 -
Acer Therapeutics Announces Partial Exercise of Over-allotment Option in Public Offering
27/12/2017 -
Emerald Health Therapeutics Awards Stock Options
27/12/2017 -
Tauriga Sciences, Inc. to Diversify $25,000 of its Balance Sheet Cash into Groestlcoin and Gain Exposure to the Crypto Currency Sector
27/12/2017 -
Ossur Hf : Transactions in relation to share buyback program
27/12/2017 -
HempAmericana Provides Detailed View Toward an Exciting 2018
27/12/2017 -
Sharecare to Present at J.P. Morgan Healthcare Conference for Fifth Consecutive Year
27/12/2017 -
Beaucoup de donneurs de sang répondent à l’appel, mais il en faut plus
27/12/2017 -
TOMI Environmental Solutions, Inc. Starts New Year With Inclusion in EPA Lists G, L, and M
27/12/2017 -
American Health Council Names Carl Roland, PharmD, MS to Industry Board
27/12/2017 -
Actinium Pharmaceuticals Provides Update on Pivotal Phase 3 Trial of Iomab-B: Independent Data Monitoring Committee Recommends SIERRA Trial Continue
27/12/2017 -
UPDATE -- Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer
27/12/2017 -
Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer
27/12/2017
Pages